1.Randomized controlled trial of darbepoetin alfa and continuous erythropoietin receptor activator once every 4 weeks in patients with chronic kidney disease at the pre-dialysis stage.
2.Body temperature rise in the cell-free and concentrated ascites reinfusion therapy (CART) is correlated to protein concentration rather than IL-6 levels in the ascites.
Noriaki Maruyama, Masanori Abe, Kazuyoshi Okada
3.Levocarnitine improves cardiac function in hemodialysis patients with left ventricular hypertrophy.
2.Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker. Journal of the Renin-Angiotensin-Aldosterone System 16: 159-164, 2015.
Abe M, Oikawa O, Okada K, Soma M
3.Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Nutrients 7: 3783-3795, 2015.
Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M
5.DPP4-inhibitors in diabetic patients with chronic kidney disease and end-stage kidney disease on dialysis in clinical practice. Contributions to Nephrology 185: 98-115, 2015.
Abe M, Okada K
6.Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis. Sleep Medicine 16: 941-948, 2015.
Higuchi T, Abe M, Mizuno M, Yamazaki T, Suzuki H, Moriuchi M, Oikawa O, Okawa E, Ando H, Okada K
7.Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease. Scandinavian Journal of Clinical and Laboratory Investigation 75: 421-427, 2015.
Abe M, Maruyama N, Oikawa O, Maruyama T, Okada K, Soma M
8.Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6. Stem Cell Research and Therapy 6: 80, 2015.
Maruyama T, Fukuda N, Matsumoto T, Kano K, Endo M, Kazama M, Kazama T, Ikeda J, Matsuda H, Ueno T, Abe M, Okada K, Soma M, Matsumoto K, Kawachi H
9.Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature. Journal of Artificial Organs 18: 285-289, 2015.
Kobayashi H, Abe M, Murata Y, Maruyama T, Furukawa T, Oikawa O, Okada K
10.A trial of pitavastatin versus rosuvastatin for dyslipidemia in chronic kidney disease. Journal of Atherosclerosis and Thrombosis 22: 1235-1247, 2015
Abe M, Maruyama N, Maruyama T, Okada K, Soma M
11.Multifunctional L/N- and L/T-type calcium channel blockers for kidney protection. Hypertension Research 38: 804-806, 2015.